Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 7276 - 7300 of 13634 in total
CTCE-0214 is a stable peptide agonist of stromal cell-derived factor-1 (SDF-1), a key signaling molecule in the proliferation, homing, engraftment and expansion of hematopoietic stem cells and white blood cells.
Investigational
Matched Description: … CTCE-0214 is a stable peptide agonist of stromal cell-derived factor-1 (SDF-1), a key signaling molecule ... in the proliferation, homing, engraftment and expansion of hematopoietic stem cells and white blood …
Investigational
Experimental
Investigational
Mentha arvensis top is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.
Experimental
Matched Description: … Mentha arvensis top is a plant/plant extract used in some OTC (over-the-counter) products. …
Investigational
Aminocamptothecin has been used in trials studying the treatment of Lymphoma, Gastric Cancer, Ovarian Cancer, Esophageal Cancer, and Ovarian Neoplasms, among others.
Investigational
Matched Description: … Aminocamptothecin has been used in trials studying the treatment of Lymphoma, Gastric Cancer, Ovarian …
Investigational
Experimental
An essential branched-chain amino acid important for hemoglobin formation. [PubChem]
Experimental
Matched Description: … An essential branched-chain amino acid important for hemoglobin formation. [PubChem] …
Investigational
Autologous hematopoietic peripheral blood stem cells were tested in a clinical trial (NCT00424489) by Northwestern University for the treatment of refractory myasthenia gravis.
Investigational
Matched Description: … Autologous hematopoietic peripheral blood stem cells were tested in a clinical trial (NCT00424489) by ... Northwestern University for the treatment of refractory myasthenia gravis. …
Experimental
Mezigdomide is under investigation in clinical trial NCT05372354 (A Study to Evaluate Safety, Drug Levels and Effectiveness of CC-92480 (BMS-986348) in Combination With Other Treatments in Participants With Relapsed or Refractory Multiple Myeloma).
Investigational
Matched Description: … Mezigdomide is under investigation in clinical trial NCT05372354 (A Study to Evaluate Safety, Drug Levels ... and Effectiveness of CC-92480 (BMS-986348) in Combination With Other Treatments in Participants With …
Investigational
CX-2009 is under investigation in clinical trial NCT03149549 (PROCLAIM-CX-2009: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2009 for Patients With Selected Solid Tumors).
Investigational
Matched Description: … CX-2009 is under investigation in clinical trial NCT03149549 (PROCLAIM-CX-2009: A Trial to Find Safe ... and Active Doses of an Investigational Drug CX-2009 for Patients With Selected Solid Tumors). …
TPMPA ((1,2,5,6-tetrahydropyridine-4-yl)methylphosphinic acid) is a selective antagonist of GABAC receptors (also known as GABA-ρ or GABAA-ρ receptors). GABAC receptors are found primarily in the retina, although they may be present in other tissues, including the hippocampus, spinal cord, superior colliculus, pituitary and the gut.[A245308,A245313] TPMPA is used as a pharmacological...
Experimental
Matched Description: … [A245308,A245313] TPMPA is used as a pharmacological probe for the investigation of GABAC ... [A245303] GABAC receptors are found primarily in the retina, although they may be present ... in other tissues, including the hippocampus, spinal cord, superior colliculus, pituitary and the gut. …
An unsaturated, essential fatty acid. It is found in animal and human fat as well as in the liver, brain, and glandular organs, and is a constituent of animal phosphatides. It is formed by the synthesis from dietary linoleic acid and is a precursor in the biosynthesis of prostaglandins, thromboxanes,...
Experimental
Matched Description: … It is found in animal and human fat as well as in the liver, brain, and glandular organs, and is a constituent ... It is formed by the synthesis from dietary linoleic acid and is a precursor in the biosynthesis of prostaglandins …
N-acetylmannosamine is under investigation for the other of GNE Myopathy.
Investigational
Matched Description: … N-acetylmannosamine is under investigation for the other of GNE Myopathy. …
Boehringer Ingelheim Pharmaceuticals’ olcegepant (BIBN 4096) is a selective Calcitonin Gene-Related Peptide (CGRP) antagonist, a new class of drugs in development for the treatment of acute migraine attacks. Olcegepant is undergoing phase II trials in Europe and the US, with preliminary results suggesting that CGRP antagonists may represent a potential...
Investigational
Matched Description: … (CGRP) antagonist, a new class of drugs in development for the treatment of acute migraine attacks. ... Olcegepant is undergoing phase II trials in Europe and the US, with preliminary results suggesting that ... CGRP antagonists may represent a potential new approach to the treatment of migraine. …
CAN-106 a novel, long-acting monoclonal antibody directed against human complement C5.
Investigational
Matched Description: … CAN-106 a novel, long-acting monoclonal antibody directed against human complement C5. …
Displaying drugs 7276 - 7300 of 13634 in total